The subjects of this study were inpatients with ACLF who were admitted to Tongji Hospital in Wuhan from March 2023 to June 2025. After patients were enrolled, The patient's general information (gender, age, past medical history, etc.), complications (ascites, hepatic encephalopathy, hepatorenal syndrome, gastrointestinal bleeding, etc.), laboratory tests (CRP, PCT, INR, WBC, fungal/bacterial diagnostic tests, etc.), symptoms and signs at the time of infection, and at admission (D1), D4, D7, D14, D21, etc.) were recorded Save the blood separately. The patients were divided into fungal infection group, bacterial infection group and non-infection group according to the infection status after admission.
Study Type
OBSERVATIONAL
Enrollment
400
Department of Infectious Disease, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China
incidence rate of bacterial or fungal infection
incidence rate of bacterial or fungal infection
Time frame: 28 days and 90 days
mortality rate of bacterial or fungal infection
mortality rate of bacterial or fungal infection
Time frame: 28 days and 90 days
incidence rate of complications
incidence rate of complications
Time frame: 28 days and 90 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.